Detailed business analysis is currently available only for mainboard IPOs.
Accretion Pharmaceuticals Limited
Price Band
₹96 - ₹101
Total Issue
₹30 Cr
Bid Dates
14 May - 16 May
Subscription
7.73x
Est. GMP
₹0 (0.00%)
Valuation
Market Cap
₹112.27 Cr
P/E Ratio
10.42x
P/B Ratio
7.55x
Accretion Pharmaceuticals IPO Dates
Conflicting IPOs
IPOs with overlapping timeline
Business Overview
Accretion Pharmaceuticals Limited is a pharmaceutical CDMO engaged in the manufacturing and marketing of a wide range of formulations including tablets, capsules, oral liquids, external preparations, and oral powders. The company operates through domestic sales, direct exports, and merchant exporter arrangements, with its products being supplied to several international markets through direct and indirect channels. With a strong focus on quality and compliance, the company caters to diverse client needs across geographies. Its operations are supported by a modern manufacturing facility and a dedicated team committed to excellence.
Accretion Pharmaceuticals IPO Lot Size
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Ind (Min) | 1 | 1,200 | ₹1,21,200 |
| Ind (Max) | 1 | 1,200 | ₹1,21,200 |
| S-HNI (Min) | 2 | 2,400 | ₹2,42,400 |
| S-HNI (Max) | 8 | 9,600 | ₹9,69,600 |
| B-HNI (Min) | 9 | 10,800 | ₹10,90,800 |
Accretion Pharmaceuticals IPO Size
Objects of Issue
- Capital expenditure towards purchase of new equipment / machineries
- Capital expenditure towards upgradation of existing manufacturing facility
- Repayment of certain borrowings availed by our Company
- Funding working capital requirements
- General Corporate Purpose
Accretion Pharmaceuticals IPO IPO Live Subscription
Updated as on 16-May-2025 19:00:05 hrs
| Category | Sub (x) | Offered | Bids |
|---|---|---|---|
| QIB | 12.14x | 1,41,600 | 17,19,600 |
| NII | 4.29x | 12,22,800 | 52,44,000 |
| Retail | 10.55x | 12,22,800 | 1,28,95,200 |
| Total | 7.68x | 25,87,200 | 1,98,58,800 |
Accretion Pharmaceuticals IPO IPO Details Live GMP
| Date | GMP (₹) | Est. Price |
|---|---|---|
| 20 May | ₹0 (0%) | ₹101 |
| 19 May | ₹0 (0%) | ₹101 |
| 17 May | ₹2 (2%) | ₹103 |
| 16 May | ₹3 (3%) | ₹104 |
| 15 May | ₹9 (8.9%) | ₹110 |
| 14 May | ₹14 (13.9%) | ₹115 |
| 13 May | ₹0 (0%) | ₹101 |
| 12 May | ₹0 (0%) | ₹101 |
| 09 May | ₹0 (0%) | ₹101 |
| 08 May | ₹0 (0%) | ₹101 |
| 07 May | ₹0 (0%) | ₹101 |
Accretion Pharmaceuticals IPO Peer Comparison
(Rs. in crores)
| Particulars | Accretion Pharma | Sakar Healthcare | Lincoln Pharmaceuticals | Sotac Pharmaceuticals |
|---|---|---|---|---|
| Revenue from Ops (in Crs.) | 33.67 | 153.35 | 580.55 | 67.11 |
| PAT (In Crs.) | 3.88 | 11.67 | 93.30 | 5.75 |
| EPS - Basic | 9.69 | 5.64 | 46.58 | 5.24 |
| NAV per share | 13.37 | 120.65 | 295.98 | 43.69 |
| RONW | 72.80% | 4.45% | 15.74% | 11.91% |
| EBITDA | 23.06% | 26.47% | 23.14% | 17.16% |
| Price to earning (PE) | 10.42 | 48.89 | 12.30 | 23.85 |
- All the information pertains to FY 2023-24
- The PE ratio is calculated using the Upper Price Band for the Issuer and the closing price as of May 05, 2025 for Peers
Accretion Pharmaceuticals IPO IPO Financial Performance
(Rs. in crores)
| Particulars | Dec-24 | Mar-24 | Mar-23 | Mar-22 |
|---|---|---|---|---|
| Revenue from Operations | 35.67 | 33.67 | 29.38 | 22.29 |
| Profit after Tax | 5.24 | 3.88 | 0.10 | 0.08 |
| Net Worth | 13.58 | 5.35 | 3.84 | 3.08 |
| Total Borrowing | 13.79 | 13.48 | 8.47 | 7.61 |
| Total Assets | 39.99 | 27.05 | 20.58 | 17.74 |
| NAV per share (in ₹) | 17.09 | 13.37 | NA | NA |
| EPS - Basic (in ₹) | 8.74 | 9.69 | NA | NA |
Key Performance Indicators (KPIs)
EBITDA
23.06%
PAT
11.51%
ROE
72.80%
ROCE
36.73%
- All Ratios are based on Mar 24
- PE, PB, and Post-Issue Market Capitalization are calculated based on the upper price band.
Promoter Holding
Promoter
3.72%
Public
96.28%
Management
Registrar & Lead Managers
Registrar
KFin Technologies
Lead Managers (1)
Company Details
Name: Accretion Pharmaceuticals Limited
Address: 29 Xcelon Ind Park 1, B/h, Intas Pharmaceuticals, Vasna Chacharvadi, Ahmedabad, Sanand, Gujarat, India, 382213
Number: +91-97148 82929
Email: compliance@accretionpharma.com
Website: http://www.accretionp harma.com
Current Live IPOs
| IPO Name | Listing Date |
|---|---|
| Bio Medica Laboratories IPO | 28 May |
| Q-Line Biotech IPO | 29 May |
| Autofurnish IPO | 29 May |
Recently Closed IPOs
| IPO Name | Listing Date |
|---|---|
| Vegorama Punjabi IPO | 27 May |
| TeamTech Formwork IPO | 26 May |
| NFP Sampoorna IPO | 25 May |
Upcoming IPOs
| IPO Name | Listing Date |
|---|---|
| Rajnandini Fashion IPO | 03 Jun |
| SMR Jewels IPO | 03 Jun |
| Merritronix IPO | 08 Jun |
Frequently Asked Questions (FAQs)
What is Accretion Pharmaceuticals IPO?
When will Accretion Pharmaceuticals IPO open?
What is the GMP of Accretion Pharmaceuticals IPO?
What is the lot size of Accretion Pharmaceuticals IPO?
When is the allotment of Accretion Pharmaceuticals IPO?
What is the listing date of Accretion Pharmaceuticals IPO?
What is the subscription of Accretion Pharmaceuticals IPO?
What is the price band of Accretion Pharmaceuticals IPO?
How to check allotment status of Accretion Pharmaceuticals IPO?
How to apply Accretion Pharmaceuticals IPO in Zerodha?
- Go to Kite App → Tap on Bids → Tap on IPO
- Select the IPO → Tap on apply → Enter UPI ID
- Enter Qty and Price
- Submit the application
- Approve the UPI Mandate on your UPI app
How to apply Accretion Pharmaceuticals IPO in Groww?
- Go to Groww App → Stocks Section → Select IPO option
- Select the IPO you want to apply
- Enter your bid details and price
- Enter UPI ID & submit
- Approve the UPI Mandate on your UPI app
How to apply Accretion Pharmaceuticals IPO using ASBA?
- Log in to your bank's net banking portal.
- Navigate to the 'IPO' or 'ASBA' section.
- Select Accretion Pharmaceuticals IPO from the list of available IPOs.
- Enter the required details: Bid quantity, Price, DP ID & Client ID, etc
- Submit the application.
- Money will remain blocked till the refund date